Sign up for free insights newsletter
28

SK Chemicals Co Ltd Pref

28513KKO

Need professional-grade analysis? Visit stockanalysis.com

₩26,700.00
+0.75%
End of day
Market Cap

$996.62B

P/E Ratio

22.32

Employees

1,365

Dividend Yield

3.05%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.00-0.550.572.120.66
Calmar-2.56-1.000.702.150.38
Sharpe82.54-0.78-0.440.391.375.87
Omega0.840.931.111.281.10
Martin-4.14-2.121.424.591.00
Ulcer0.006.147.6210.5810.068.52

SK Chemicals Co Ltd Pref (28513K) Price Performance

SK Chemicals Co Ltd Pref (28513K) trades on KO in KRW. The company is classified in the Basic Materials sector under the Specialty Chemicals industry. The stock currently trades at KRW26700.00, up 0.75% from the previous close.

Over the past year, 28513K has traded between a low of KRW18275.62 and a high of KRW31850.00. The stock has gained 46.1% over this period. It is currently 16.2% below its 52-week high.

SK Chemicals Co Ltd Pref has a market capitalization of $996.62B, with a price-to-earnings ratio of 22.32 and a dividend yield of 3.05%.

About SK Chemicals Co Ltd Pref

SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea, China, Japan, Asia, the United States, Europe, and internationally. The company offers copolyester, engineering plastic, petro chemical, specialty chemical, coating and adhesive, biomaterial, and performance chemical for covid-19 personal protective equipment, industrial materials, sustainable packaging solution, packaging, cosmetic, automotive, consumer goods and sports, and electronics and home appliance applications. It sells its products under the SKYGREEN, SKYPEL, SKYBON, ECOZEN, SKYTRA, ECOTRION, CLARO, SKYDMT, CnR, ECOTRIA, SKYCHDM, E.Chemical, SKYPET, SKYDMCD, SKYPURA, and SKYCHDA brands. The company provides ETC drugs, including musculoskeletal system, anti-inflammatory agents/analgenics, digestive system, central nervous system, respiratory system, urinary system, kidney/rheumatism, circulatory system/metabolic disease, antimicrobial/antiviral agents, and others; OTC drugs, such as common cold/antihistamine, drugs to improve blood flow, vitamins/minerals, dermatologicals, and other products. The company was founded in 1969 and is headquartered in Seongnam-si, South Korea.

Company Info

Exchange
KO
Currency
KRW

Financial Metrics

Revenue (TTM)
$2.37T
EBITDA
$188.57B
Profit Margin
1.89%
EPS (TTM)
N/A
Book Value
2259328.66

Technical Indicators

52 Week High
₩34,300.00
52 Week Low
₩17,910.89
50 Day MA
₩27,573.00
200 Day MA
₩27,849.50
Beta
1.03

Valuation

Trailing P/E
22.32
Forward P/E
N/A
Price/Sales
0.42
Price/Book
0.22
Enterprise Value
$1.59T